Trump’s drugmaker deals may save economy $529B over 10 years, White House says
The administration says the plan could also cut Medicaid spending by $64.3 billion as Democrats question the unpublished deal terms.
- White House economists estimate President Donald Trump's deals with pharmaceutical companies could save $529 billion over 10 years by aligning U.S. prescription drug prices with international rates.
- Trump is leveraging his "most favored nation" policy to address affordability concerns, ensuring U.S. prescription drug costs are no longer dramatically higher than in other affluent nations.
- Americans spent $467 billion on prescription drugs in 2024, while The Congressional Budget Office estimated a similar plan could reduce prices by more than 5% over time.
- Senate Finance Committee Ranking Member Ron Wyden and Senate Democrats proposed a measure in April requiring the administration to disclose terms of the pharmaceutical agreements.
- Staff for Sen Bernie Sanders, I-Vt, analyzed 15 companies in the plan and found their profits jumped 66% over the past year, as critics argue pharmaceutical companies increased margins while working with the administration.
40 Articles
40 Articles
White House estimates Trump's Big Pharma dealmaking will save Americans $529 billion over the next 10 years
White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House an…
Trump’s drugmaker deals may save U.S. economy $529B over 10 years, White House says
White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years.
Trump quietly saves Americans $529 billion; mainstream ignores?
White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years. The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House an…
White House Says Trump Drug Deals Could Save $529B
The White House estimates that President Donald Trump’s drug pricing deals with pharmaceutical companies could save the U.S. economy $529 billion over the next decade, according to an analysis reported by the Associated Press. The report said the policy aims to align U.S. prescription drug prices with those in other developed countries. Officials from the White House Council of Economic Advisers also projected $64.3 billion in savings for Medica…
Trump's drugmaker deals may save economy $529B over 10 years, White House says | 100.1 FM and AM 1020 KDKA
President Donald Trump’s deals with drugmakers requiring many of their U.S. prescription prices to drop could save the economy $529 billion over the next decade | 100.1 FM and AM 1020 KDKA
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
